Clinical Practice Guidelines
AAHKS has produced these guidelines specifically for hip and knee surgeons to use in their practices. Practice ResourcesOpioids in TJA
Description:The purpose of these guidelines is to improve the treatment of orthopedic surgical patients and reduce practice variation by promoting a multidisciplinary evidence-based approach on the use of opioids following primary TJA. The guideline can also be found here.
Year released: 2020
Ketamine in Total Joint Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of primary TJA patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach to the use of ketamine in primary TJA. The guideline can also be found here.
Year released: 2022
Regional Nerve Blocks in Primary Total Knee Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of orthopedic surgical patients and reduce practice variationby promoting a multidisciplinary evidence-based approach to the use of regional nerve blocks following primary TKA. The guideline can also be found here.
Year released: 2022
Regional Nerve Blocks in Primary Total Hip Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of orthopedic surgical patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach to the use of regional nerve blocks following primary THA. The guideline can also be found here.
Year released: 2022
Periarticular Injection in Total Joint Arthroplasty
Description: The purpose of these guidelines are to improve the treatment of primary TJA in patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach for the use of periarticular injectionin primary TJA. The guideline can also be found here.
Year released: 2022
Prevention of Total Hip and Knee Arthroplasty Periprosthetic Joint Infection in Patients Undergoing Dental Procedures
Description: This guideline is based on a systematic review of published studies examining the influence of dental care and procedures on outcomes after total joint arthroplasty (TJA) as well as strategies to mitigate potential risks associated with dental care in patients with a TJA. The guideline can also be found here.
Year released: 2024
Acetaminophen in Total Joint Arthroplasty:
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of acetaminophen following primary TJA. The guideline can also be found here.
Year released: 2020
Tranexamic Acid Use in Total Joint Arthroplasty:
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidence-based approach on the use of TXA. The guideline can also be found here.
Year released: 2018
Optimal Timing of Elective Hip or Knee Arthroplasty
Description: This purpose of this guideline is to develop evidence-based consensus recommendations for the optimal timing of hip and knee arthroplasty to improve patient-important outcomes. The guideline can also be found here.
Year released: 2023
Corticosteroids in Total Joint Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of primary TJA patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach to the use of corticosteroids following primary TJA. The guideline can also be found here.
Year released: 2022
Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Description: The purpose of this guideline is to develop updated ACR guidelines for the perioperative management of disease-modifying medications for patients with rheumatic diseases. The guideline can also be found here.
Year released: 2022
